Over 500 New Jersey Auctions End Tomorrow 01/18 - Bid Now
Over 2050 Total Lots Up For Auction at Five Locations - OK 01/19, NJ Cleansweep 01/20, CA 01/21, NY 01/24, Jutland 01/27


Philips and Ibex partner to support pathology diagnostics
Targeting improved workflow and productivity, faster and more accurate diagnoses
Siemens to be primary supplier for Quest Diagnostics immunoassay testing
Will distribute up to 120 Atellica immunoassay analyzers
New tool brings quality control to digital pathology
Validates slides useful for diagnosis
Understanding the value of digital pathology
Producing many of the same benefits today that were seen with PACS 30 years ago
GE and VUMC partner to make cancer immunotherapy safer and more precise
Five-year collab will yield new AI apps and PET tracers
Precision X-Ray and Faxitron Bioptics combine business assets
Forming a new global leader in biological irradiation
Philips and LabCorp partner to further the adoption of digital pathology
Bringing a digitized workflow into its anatomic pathology services
AI approach used to study Mars now assessing tumor response to therapies
Could reduce sample sizes and accelerate process for approval of cancer therapies
Siemens installs first US-based Atellica Solution
Offers flexibility to simplify testing workflow
Philips taps Mass. General and Brigham & Women's to enhance digital pathology
Using IntelliSite solution for clinical and research purposes
Artificial intelligence. Machine learning. Automation. Computer vision.
He's why it's time to stop being afraid of theese phrases...
Computerized tissue imaging may predict who will benefit from chemotherapy
NCI-funded trial to investigate this technology
Working on the next generation of wearables at University of Cincinnati
Examining the challenges and potential for wearable biosensors
Inspirata buys GE's digital pathology venture, Omnyx
Will integrate Dynamyx into its digital pathology solution
GE partners with Roche to develop digital clinical decision support solutions
Initial focus on cancer and critical care patients
In the next five years the field of pathology will experience a rapid evolution
A look at one company hoping to seize the opportunity